AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
M2 PRESSWIRE-27 November 2000-SMI: SMi are pleased to announce that eResearch Technologies are to sponsor their Pharmacovigilance: Perspectives & Future Directions Conference (C)1994-2000 M2 COMMUNICATIONS LTD
RDATE:27112000
Learn to co-ordinate and communicate pharmacovigilance rapidly and efficiently by attending
Pharmacovigiliance: Perspectives & Future Directions
21st to 22nd February, The Hatton, London
It is only recently that pharmacovigilance has received the prominence that it deserves as a result of ADR reporting coming under close scrutiny over the past few years. It has been recognised that ADRs may be responsible for more than 100,000 US deaths nation-wide each year - making it one of the leading causes of death (Lazarou et al., 1998). Incredibly, it is now believed that ADRs are ranked fourth leading cause of death behind heart disease, cancer and strokes.
With this knowledge in mind, our challenge at SMi was to assemble key industry peers from across the pharmaceutical spectrum that would provide pertinent and up-to-date information on pharmacovigilance - an arena that remains in constant flux. As you can see from this brochure we have achieved our goal.